13F Holdings
中文EN

LCTC Lifeloc Technologies, Inc

Laboratory Analytical Instruments · OTC · SEC CIK 1493137 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.0%
TTM net income YoY-49.9%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR—

Margins

Gross margin42.7%
Operating margin-6.5%
Net margin-19.9%
FCF margin-3.8%
EBITDA margin-3.0%

Returns

ROE-40.5%
ROA-24.7%
ROIC (approx.)-9.9%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets46.7%
Debt / equity0.27x
Current ratio3.95x
Interest coverage-4.24x

Cash quality & payout

Operating cash flow / net income-0.03x
Accruals ratio-25.6%
Payout ratio—
Capex / revenue4.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$9.03M$8.54M$9.33M$8.48M$7.05M
Cost of revenue$5.38M$5.09M$5.29M$5.41M$3.99M
Gross profit$3.64M$3.45M$4.04M$3.07M$3.06M
R&D expense$2.15M$2.24M$1.84M$1.39M$1.21M
SG&A expense$1.39M$1.25M$1.17M$1.22M$1.11M
Operating income-$1.23M-$1.41M-$191,135-$650,345-$268,913
Interest expense$119,190$40,145$41,566$43,081$51,272
Pretax income———-$572,737$619,660
Income tax$1.16M-$352,547-$368,253-$116,980-$56,307
Net income-$2.47M-$1.05M$205,614-$455,757$675,967
EBITDA-$786,566-$1.11M$73,689-$17,927-$14,090
EPS (basic)-0.90-0.410.08-0.190.28
EPS (diluted)-0.90-0.410.08-0.190.27
Weighted avg. shares (diluted)2.74M2.55M2.45M2.45M2.52M
Balance sheet
Cash & equivalents$746,001$1.24M$1.77M$2.35M$2.57M
Receivables$772,380$732,541$812,126$627,919$562,092
Inventory$2.63M$3.00M$3.02M$2.73M$2.67M
Current assets$4.27M$5.09M$5.71M$5.88M$5.86M
PP&E, net$2.30M$2.38M$2.00M$2.25M$2.59M
Intangibles$71,039$78,723$64,439$69,679$134,428
Total assets$6.69M$8.72M$8.69M$8.52M$8.95M
Current liabilities$836,870$743,575$1.15M$1.14M$1.08M
Short-term debt—$53,195$51,588$50,028$48,513
Long-term debt$1.06M$1.12M$1.17M$1.22M$1.27M
Total debt$1.06M$1.17M$1.22M$1.27M$1.32M
Total liabilities$2.58M$2.50M$2.33M$2.36M$2.36M
Shareholders' equity$4.10M$6.23M$6.36M$6.16M$6.59M
Net debt$312,425-$71,399-$544,790-$1.08M-$1.26M
Shares outstanding2.75M2.66M2.45M2.45M2.45M
Cash flow statement
Operating cash flow-$499,319-$1.33M-$525,740$54,325$182,943
Capital expenditure$462,793$539,731$6,811$213,206$265,867
Free cash flow-$962,112-$1.87M-$532,551-$158,881-$82,924
Investing cash flow-$354,381-$689,446-$8,215-$222,576-$268,476
Financing cash flow$355,955$1.49M-$52,178-$50,663$462,131
Depreciation & amortization$443,454$294,039$264,824$632,418$254,823
Stock-based compensation——$0$17,202$17,157

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.